126 related articles for article (PubMed ID: 27172253)
1. Low-Dose Chemoreduction for Infants Diagnosed with Retinoblastoma before 6 Months of Age.
Berry JL; Jubran R; Lee TC; Murphree AL; Lee D; Kim JW
Ocul Oncol Pathol; 2015 Feb; 1(2):103-10. PubMed ID: 27172253
[TBL] [Abstract][Full Text] [Related]
2. Chemoreduction for group E retinoblastoma: comparison of chemoreduction alone versus chemoreduction plus low-dose external radiotherapy in 76 eyes.
Shields CL; Ramasubramanian A; Thangappan A; Hartzell K; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2009 Mar; 116(3):544-551.e1. PubMed ID: 19157557
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of Group D eyes in bilateral retinoblastoma patients treated with chemoreduction and low-dose IMRT salvage.
Berry JL; Jubran R; Kim JW; Wong K; Bababeygy SR; Almarzouki H; Lee TC; Murphree AL
Pediatr Blood Cancer; 2013 Apr; 60(4):688-93. PubMed ID: 22997170
[TBL] [Abstract][Full Text] [Related]
4. Globe salvage using chemoreduction for advanced retinoblastoma in a glaucomatous eye with buphthalmos.
Parvus BJ; Salazar PF; Shields CL; Shields JA
Retin Cases Brief Rep; 2009; 3(1):1-3. PubMed ID: 25390824
[TBL] [Abstract][Full Text] [Related]
5. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
Gündüz K; Shields CL; Shields JA; Meadows AT; Gross N; Cater J; Needle M
Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
[TBL] [Abstract][Full Text] [Related]
6. Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.
Berry JL; Kogachi K; Aziz HA; McGovern K; Zolfaghari E; Murphree AL; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 28221729
[TBL] [Abstract][Full Text] [Related]
7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
8. Chemoreduction for unilateral retinoblastoma.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Naduvilath TJ
Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of Group D retinoblastoma eyes during the intravitreal melphalan era.
Berry JL; Shah S; Bechtold M; Zolfaghari E; Jubran R; Kim JW
Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28646513
[TBL] [Abstract][Full Text] [Related]
10. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
Shields CL; Honavar SG; Meadows AT; Shields JA; Demirci H; Singh A; Friedman DL; Naduvilath TJ
Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
[TBL] [Abstract][Full Text] [Related]
11. Long-Term Outcomes of Group B Eyes in Patients with Retinoblastoma Treated with Short-Course Chemoreduction: Experience from Children's Hospital Los Angeles/University of Southern California.
Zhu D; Berry JL; Ediriwickrema L; Wong K; Lee TC; Murphree AL; Kim JW; Jubran R
Ocul Oncol Pathol; 2015 Dec; 2(2):105-11. PubMed ID: 27172535
[TBL] [Abstract][Full Text] [Related]
12. The International Classification of Retinoblastoma predicts chemoreduction success.
Shields CL; Mashayekhi A; Au AK; Czyz C; Leahey A; Meadows AT; Shields JA
Ophthalmology; 2006 Dec; 113(12):2276-80. PubMed ID: 16996605
[TBL] [Abstract][Full Text] [Related]
13. Effect of Intravenous Chemotherapy Regimen on Globe Salvage Success Rates for Retinoblastoma Based on Disease Class-A Meta-Analysis.
Daniels AB; Patel SN; Milam RW; Kohanim S; Friedman DL; Koyama T
Cancers (Basel); 2021 May; 13(9):. PubMed ID: 34066325
[TBL] [Abstract][Full Text] [Related]
14. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
15. Iodine 125 plaque radiotherapy as salvage treatment for retinoblastoma recurrence after chemoreduction in 84 tumors.
Shields CL; Mashayekhi A; Sun H; Uysal Y; Friere J; Komarnicky L; Shields JA
Ophthalmology; 2006 Nov; 113(11):2087-92. PubMed ID: 16949158
[TBL] [Abstract][Full Text] [Related]
16. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
17. Retinoblastoma in Jordan, 2003-2013: ocular survival and associated factors.
Al-Nawaiseh I; Jammal HM; Khader YS; Jaradat I; Barham R
Ophthalmic Epidemiol; 2014 Dec; 21(6):406-11. PubMed ID: 25317653
[TBL] [Abstract][Full Text] [Related]
18. Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma.
Abramson DH; Daniels AB; Marr BP; Francis JH; Brodie SE; Dunkel IJ; Gobin YP
PLoS One; 2016; 11(1):e0146582. PubMed ID: 26756643
[TBL] [Abstract][Full Text] [Related]
19. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
20. Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma.
Shields CL; Shields JA; Needle M; de Potter P; Kheterpal S; Hamada A; Meadows AT
Ophthalmology; 1997 Dec; 104(12):2101-11. PubMed ID: 9400771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
